Exelixis Clinical Site #34

Seoul 05505

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Differentiated Thyroid Cancer

Studies at this site

• Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer — Running, not enrolling
• A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy — Running, not enrolling